At a glance
- Originator GlaxoSmithKline
- Developer GSK
- Class Antibacterials; Penicillins
- Mechanism of Action Cell wall inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Bacterial infections
Most Recent Events
- 26 May 1995 Discontinued-Preclinical for Bacterial infections in United Kingdom (PO)